Amplify or Hedge investment returns with the first Leveraged and Inverse Products on SGX!
Tiger Brokers (Singapore) is proud to be one of the exclusive participating dealers for the Initial Offering Period (IOP) of Phillip MSCI Singapore Daily (2X) Leveraged Product and the Phillip MSCI Singapore Daily (-1X) Inverse Product.
The Exchange Traded Products (collectively as “Phillip L&I Products”) provide investors with:
-
Leveraged or Inverse exposure to the MSCI Singapore Index which represents approximately 85% of Singapore large & mid cap equities
-
Daily reset of Leverage and Inverse Exposures
- No daily margin monitoring as it is managed by professional fund managers
- An effective tool for amplifying investment returns in a Bull Market or for hedging investment risks in a Bear Market
You can trade this Leveraged and Inverse Exchange-Traded Products from 01 December 2021 onwards!
Exchange Traded Products (ETP) are categorized as SIPs (Specified Investment Products); which may only be suitable for clients who have met CAR (Customer Account Review) and/or CKA (Client Knowledge Assessment) requirements.
ZERO Charges* for the subscription of the Exchange Traded Products (collectively as “Phillip L&I Products”) during the Initial Offer Period from 22 November 2021 to 24 November 2021
Clients will be able to apply via the Tiger Trade App during the subscription period from 22 November 2021, 9am to 24 November 2021, 12pm. There will be ZERO charges* for this IOP. Terms and conditions apply*.
Terms & conditions click here
Allotment of subscription is not guaranteed and subjected to the product manager’s discretion. In the event of a nil transaction, clients will be refunded and have their funds credited back to their Tiger Account latest by 1 December 2021, 9am.
For more information, please refer to the Prospectus and Index Design.
Name of Counter |
PHIL LONG SIMSCI2X |
Listing Price |
SGD 2.00 |
Traded Currencies |
SGD and USD For the IOP, the subscription will be denominated in SGD |
Tiger Brokers Subscription Period |
22 November 2021, 9am to 24 November 2021, 12pm |
Subscription Quantity |
Min 100 units, in multiples of 100 units |
Allocation |
Allotment for this IOP is not guaranteed |
Subscription Fees |
NIL* |
Listing Date |
01 December 2021 (Thursday) |
Name of Counter |
PHIL SHORT SIMSCI-1X |
Listing Price |
SGD 2.00 |
Traded Currencies |
SGD and USD For the IOP, the subscription will be denominated in SGD |
Tiger Brokers Subscription Period |
22 November 2021, 9am to 24 November 2021, 12pm |
Subscription Quantity |
Min 100 units, in multiples of 100 units |
Allocation |
Allotment for this IOP is not guaranteed |
Subscription Fees |
NIL* |
Listing Date |
01 December 2021 (Thursday) |
Please refer to Phillip Capital Management’s website for more information:
https://phillipfunds.com/li-etf
This advertisement has not been reviewed by the Monetary Authority of Singapore.
Any views shared with Prospective Clients (“Prospects”) are suggestive in nature and on a sample basis only. This may also be predicated on assumptions that are made by Tiger Brokers (Singapore) Pte. Ltd. (“Tiger Brokers”) about the Prospects’ investment objectives and risk profile. Our suggestive and sample views extended to Prospects are not to be considered as recommendations made by Tiger Brokers. Suggestions provided are also based on information that may be shared by the Prospects, the accuracy and comprehensiveness of which Tiger Brokers is not in a position to verify.
Tiger Brokers may, to the extent permitted by law, participate or invest in other transactions with the issuer of the products referred to herein, perform services or solicit business from such issuers, and/or have a position or effect transactions in the securities or options thereof. The information herein is for recipient’s information only and not an offer to sell or a solicitation to buy. Any date or price information is indicative only and may be changed without prior notice. All opinions expressed and facts referred to herein are subject to change without notice. The information herein was obtained and derived from sources that we believe are reliable, but while reasonable care has been taken to ensure that stated facts are accurate and opinions are fair and reasonable, Tiger Brokers does not represent that it is accurate or complete and it should not be relied upon as such. The information expressed herein is current and does not constitute an offer, recommendation or solicitation, nor does it constitute any prediction of likely future stock performance. Investment involves risk. The price of investment instruments can and do fluctuate, and any individual instrument may experience upward or downward movements, and under certain circumstances may even become valueless. Past performance is not a guarantee of future results. In preparing this information, we did not take into account the investment objectives, financial situation or particular needs of any person or affiliated companies. Before making an investment decision, you should speak to a financial adviser to consider whether this information is appropriate to your needs, objectives and circumstances. Tiger Brokers assumes no fiduciary responsibility or liability for any consequences financial or otherwise arising from trading in securities if opinions and information in this document may be relied upon.